• AI-Powered Telehealth Provider with Modular, No-Code/Low-Code Platform.

• 1,000+ Clients Including NASA, U.S. Department of Health and Human Services, McKesson, DaVita, and the Entire Nation of Qatar.

• Enabling Seamless, Scalable and Secure Digital Health Solutions Across Hospitals, Governments and Enterprise Organizations.

• "Lego-like" Digital Health Building Blocks to Design a Flexible Telehealth System
  
  
• System Feature Seamless Electronic Health Record (EHR) Integration, Advanced Data Visualizations and Other Scalable Capabilities for Future Needs.

• Launched New AI Doctor Notes Which Reduces Documentation Time 93%.

• Company Granted Nasdaq Approval for Continued Listing.

• Teleradiology Expansion to 25 Hospitals for an Estimated $3.0 Million Annualized Revenue.

• Selected to Support NIH-Funded Phase 3 Clinical Study on Stroke Recovery Telerehabilitation.

VSee Health (Nasdaq: VSEE) is a leading provider of telehealth solutions, specializing in real-time virtual care, clinical review, and billing services. Its technology powers healthcare networks and organizations worldwide, enabling seamless patient-provider interactions and ensuring efficient care delivery. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, VSEE highly scalable, customizable telehealth building blocks each meet stringent security standards.

VSEE has deployed services in over 50 countries, including Iraq, Syria, Marshall Islands and El Salvador. Clients include NASA, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire country of Qatar. VSEE also provides tailored solutions for critical shortage areas such as critical care and teleradiology. VSEE is committed to empowering high quality healthcare access and reducing physician burnout and workforce shortages through its telehealth technology

VSEE has a strategic partnership with AbundaBox to launch AbundaLife™, a groundbreakinghealth record management platform.This innovative solution addresses one of the most pressing challenges in healthcare—fragmented medical records—by consolidating personal health data into one secure, comprehensive profile. AbundaLife, supported by VSEE Health’s dynamic technology, empowers individuals to manage their health more effectively, enabling providers to deliver better-coordinated care and improving health outcomes.

VSEE also has an agreement wih Ava Robotics, a developer of intelligent robots for the workplace, to develop telepresence solutions for the inpatient intensive care market, including the development of a VSEE-powered Ava robot that allows providers to extend their reach and provide personalized care remotely.

VSEE Secures Nasdaq Approval for Continued Listing

On September 24th VSEE announced that the Company was notified that the Nasdaq Hearings Panel had granted the Company's request for continued listing on Nasdaq, subject to the Company (i) evidencing compliance with Nasdaq's periodic reporting requirement by filing its Q1 and Q2 Quarterly report ending March 31, 2025 and June 30, 2025 respectively on Form 10-Q by October 15, and (ii) demonstrating compliance with the Equity Rule by December 1, 2025.

VSEE continues to work diligently with its auditor to complete and file the Delayed Reports and expects to do so within the extension period granted by the Panel. VSEE also plans to address and meet the net equity requirements within the extension period.

VSEE Teleradiology Expands to 25 Hospitals for an Estimated $3.0 Million Annualized Revenue

On September 2nd VSEE announced the expansion implementation of 17 of 25 teleradiology hospitals. VSEE was awarded an increase to 22 hospitals by a significant vendor who recently awarded an additional 3 hospitals. VSEE has now implemented 17 of those hospitals by end of August this year. The contract value with this expansion is almost 3 million per year in ARR.

The initial pilot of 3 hospitals in May of 2025 has led to a rapid growth and integration of 17 hospitals over the 1st 3 months. VSEE aims to improve diagnostic accuracy, accelerate turnaround times for imaging results, and enhance patient outcomes through seamless, 24/7 radiology interpretations.

Highlights of VSEE Teleradiology Solutions:

Improved Diagnostic Efficiency: VSEE delivers real-time, remote interpretation of X-rays, MRIs, and CT scans, reducing delays in patient diagnosis and treatment initiation.

Enhanced Flexibility for Radiologists: VSEE technology enables radiologists to provide expertise from any location, ensuring round-the-clock coverage without disrupting workflow.

Customizable Cloud Clinic: The VSEE platform allows integration with existing systems, facilitating smooth consultations, second opinions, and real-time collaboration with specialists.

VSEE teleradiology services leverage cutting-edge telemedicine tools to connect radiologists with healthcare providers across hospitals, nursing facilities, and mobile clinics. Through cloud-based imaging platforms, radiologists can interpret scans, collaborate with physicians and hospitals in real-time, eliminating geographic limitations and improving operational efficiency.

AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911

On July 14th VSEE announced the launch of its new AI Doctor Notes, one of the solutions in its AI solutions suite. VSEE has partnered with Tele911, the largest national telemedicine emergency room diversion service, to integrate VSEE AI Doctor Notes into its virtual emergency care workflow. Emergency medicine demands rapid decision-making and high patient throughput. The integration has drastically reduced Tele911 physician’s charting time by 93% from 15 minutes per visit to under 1 minute, potentially increasing physician visit capacity.

This new VSEE AI solution automatically transcribes visits and generates structured SOAP notes with ICD codes in two clicks, allowing Tele911 physicians to reclaim valuable time. Now, instead of manual documentation, clinicians can focus on patient care.

Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial

On June 23rd VSEE announced it has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke survivors while reducing costs like transportation, caregiver burdens, and hospital readmissions.

The proven efficacy of Phase 3 trials opens doors for Medicare and private payer reimbursement and opportunities in the $328M global stroke rehab market, where telehealth could disrupt traditional physical therapy with better adherence and lower costs. Success also paves the way for gamified telerehabilitation in other areas, e.g. multiple sclerosis, spinal cord injury, and traumatic brain injury rehab.

For more information on $VSEE visit: www.vseehealth.com

DISCLAIMER: https://corporateads.com/disclaimer/

Disclosure listed on the CorporateAds website

Media Contact
Company Name: Vsee Health, Inc.
Contact Person: Milton Chen
Email: Send Email
Phone: 626-513-1824
Address:One Gateway Center Suite 507 300 Washington St.
City: Newton
State: Massachusetts
Country: United States
Website: www.vseehealth.com